05/21/2013
https://www.congress.gov...
"If we don't allow enough data exclusivity time, we're not going to develop these therapies, especially in bio, because bio is one of four or five places, four or five techniques, where we can actually..."
"If we reduce that data exclusivity time, especially with regard to bio, you're talking about having to charge a lot more..."
"I'm very concerned about data exclusivity."
"Do you believe, as prior commissioners have--every one has told me this--that the Dietary Supplement Health and Education Act, DSHEA, provides adequate authority to regulate the dietary supplement ind..."